COVID-19 vaccine: Bharat Biotech's Covaxin commences Phase-3 trial at AIIMS

Phase-three of human clinical trial of the India-made COVID-19 vaccine candidate Covaxin began at AIIMS in Delhi on Thursday with Dr MV Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose.

Phase-three of human clinical trial of the India-made COVID-19 vaccine candidate Covaxin began at AIIMS in Delhi on Thursday with Dr MV Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose. November 27, 2020 at 10:01AM https://ift.tt/33jJpyR